EBR Systems accelerates WiSE rollout as U.S. implants double and Australian review fast-tracked

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has shared an announcement.

EBR Systems reported strong early commercial traction for its WiSE CRT System in the first quarter of 2026, with U.S. implant volumes more than doubling from the prior quarter to 41 procedures and total commercial implants reaching 71, driving quarterly revenue of about US$2.4 million. The company expanded its Limited Market Release infrastructure by signing 16 new purchase agreements, training 22 additional physicians to a total of 55, and advancing clinical studies to strengthen evidence for WiSE, underpinned by a cash position of US$33.5 million at the end of March.

Subsequent to the quarter, EBR secured Priority Review Determination from Australia’s Therapeutic Goods Administration for the WiSE system, paving the way for accelerated inclusion on the Australian Register of Therapeutic Goods and potentially earlier access for eligible heart failure patients. Management also undertook a 1-for-10 reverse stock split of common stock, adjusted the CDI conversion ratio without diluting holders, and increased investment in manufacturing, commercial infrastructure and investor engagement to support broader adoption and long-term growth of its wireless pacing technology.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.43 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

EBR Systems, Inc. is a medical device company focused on cardiac rhythm management, developing the WiSE cardiac resynchronisation therapy system, the world’s only wireless cardiac pacing device for heart failure patients. The company targets patients with limited options for conventional CRT, with an initial commercial focus on the U.S. market and plans to expand access in other regions such as Australia.

Average Trading Volume: 495,668

Technical Sentiment Signal: Sell

Current Market Cap: A$2.7B

See more insights into EBR stock on TipRanks’ Stock Analysis page.